Next-generation sequencing (NGS) has revolutionized how molecular biology studies are
conducted. Its decreasing cost and increasing throughput permit profiling of
genomic,
transcriptomic, and epigenomic features for a wide range of applications. Microfluidics
has been proven to be highly complementary to NGS technology with its unique capabilities
for handling small volumes of samples and providing platforms for automation, integration,
and multiplexing. In this article, we review recent progress on applying microfluidics to
facilitate genome-wide studies. We emphasize on several technical aspects of NGS and how
they benefit from coupling with microfluidic technology. We also summarize recent efforts
on developing microfluidic technology for genomic, transcriptomic, and epigenomic studies, with
emphasis on single cell analysis. We envision rapid growth in these directions, driven by the
needs for testing scarce primary cell samples from patients in the context of precision
medicine.